Clinical Trial

Diagnostic Yield and Safety of Lung Biopsy Techniques in Interstitial Lung Diseases

Study acronym: DYSAFE-ILD
Completed
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the diagnostic yield and safety of different lung biopsy techniques in patients with interstitial lung diseases (ILD). The study compares transbronchial lung biopsy using forceps, transbronchial cryobiopsy, and thoracoscopic lung biopsy in terms of their ability to provide accurate diagnosis and associated complications. Interstitial lung diseases represent a heterogeneous group of diffuse parenchymal lung disorders that often require histopathological confirmation. This study will help determine the most effective and safest biopsy technique to improve diagnostic accuracy and patient outcomes.
Trial Details
NCT Number NCT07432503
Lead Sponsor Mansoura University
Conditions Interstitial Lung Diseases (ILD), Hypersenstivity Pneumonitis
Enrollment 60 participants
Start Date 2022-05-15
Primary Completion 2024-03-05 (estimated)
Study Completion 2024-10-23 (estimated)
Updated on ClinicalTrials.gov 2026-02-25